Envestnet Portfolio Solutions, Inc. Catalyst Pharmaceuticals, Inc. Transaction History
Envestnet Portfolio Solutions, Inc.
- $24.4 Billion
- Q2 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 23,376 shares of CPRX stock, worth $509,363. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,376
Previous 8,690
169.0%
Holding current value
$509,363
Previous $210,000
141.43%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
387Shares Held
99.8MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$407 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$185 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$121 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$74.6 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$68.3 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.24B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...